These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16101582)

  • 1. Topological descriptors in modeling the HIV inhibitory activity of 2-aryl-3-pyridyl-thiazolidin-4-ones.
    Prabhakar YS; Rawal RK; Gupta MK; Solomon VR; Katti SB
    Comb Chem High Throughput Screen; 2005 Aug; 8(5):431-7. PubMed ID: 16101582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of 2-(2,6-dihalophenyl)-3-pyrimidinyl-1,3-thiazolidin-4-one analogues as anti-HIV-1 agents.
    Rawal RK; Tripathi R; Katti SB; Pannecouque C; De Clercq E
    Bioorg Med Chem; 2007 May; 15(9):3134-42. PubMed ID: 17349793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CP-MLR directed QSAR studies on the antimycobacterial activity of functionalized alkenols--topological descriptors in modeling the activity.
    Gupta MK; Sagar R; Shaw AK; Prabhakar YS
    Bioorg Med Chem; 2005 Jan; 13(2):343-51. PubMed ID: 15598557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and QSAR studies on thiazolidinones as anti-HIV agents.
    Rawal RK; Solomon VR; Prabhakar YS; Katti SB; De Clercq E
    Comb Chem High Throughput Screen; 2005 Aug; 8(5):439-43. PubMed ID: 16101583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-(Aryl)-3-furan-2-ylmethyl-thiazolidin-4-ones as selective HIV-RT inhibitors.
    Rawal RK; Prabhakar YS; Katti SB; De Clercq E
    Bioorg Med Chem; 2005 Dec; 13(24):6771-6. PubMed ID: 16198576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graph theory concepts in the rationales of anti HIV-1 compounds.
    Debnath U; Katti SB; Prabhakar YS
    Curr Comput Aided Drug Des; 2013 Dec; 9(4):472-81. PubMed ID: 24138418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monte Carlo sampling and multivariate adaptive regression splines as tools for QSAR modelling of HIV-1 reverse transcriptase inhibitors.
    Alamdari RF; Mani-Varnosfaderani A; Asadollahi-Baboli M; Khalafi-Nezhad A
    SAR QSAR Environ Res; 2012 Oct; 23(7-8):665-82. PubMed ID: 22746992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, HIV-1 RT inhibitory, antibacterial, antifungal and binding mode studies of some novel N-substituted 5-benzylidine-2,4-thiazolidinediones.
    Bahare RS; Ganguly S; Choowongkomon K; Seetaha S
    Daru; 2015 Jan; 23(1):6. PubMed ID: 25617150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New thiourea and 1,3-thiazolidin-4-one derivatives effective on the HIV-1 virus.
    Bielenica A; Sanna G; Madeddu S; Struga M; Jóźwiak M; Kozioł AE; Sawczenko A; Materek IB; Serra A; Giliberti G
    Chem Biol Drug Des; 2017 Nov; 90(5):883-891. PubMed ID: 28434186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and anti-HIV studies of 2-adamantyl-substituted thiazolidin-4-ones.
    Balzarini J; Orzeszko B; Maurin JK; Orzeszko A
    Eur J Med Chem; 2007 Jul; 42(7):993-1003. PubMed ID: 17321639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QSAR study about ATP-sensitive potassium channel activation of cromakalim analogues using CP-MLR approach.
    Sharma S; Prabhakar YS; Singh P; Sharma BK
    Eur J Med Chem; 2008 Nov; 43(11):2354-60. PubMed ID: 18353509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-(2,6-Dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Rao A; Balzarini J; Carbone A; Chimirri A; De Clercq E; Monforte AM; Monforte P; Pannecouque C; Zappalà M
    Antiviral Res; 2004 Aug; 63(2):79-84. PubMed ID: 15302136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QSAR study on some anti-HIV HEPT analogues using physicochemical and topological parameters.
    Gayen S; Debnath B; Samanta S; Jha T
    Bioorg Med Chem; 2004 Mar; 12(6):1493-503. PubMed ID: 15018923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QSAR for anti-HIV activity of HEPT derivatives.
    Bazoui H; Zahouily M; Boulajaaj S; Sebti S; Zakarya D
    SAR QSAR Environ Res; 2002 Oct; 13(6):567-77. PubMed ID: 12479372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural requirements for potent anti-human immunodeficiency virus (HIV) and sperm-immobilizing activities of cyclohexenyl thiourea and urea non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    D'Cruz OJ; Venkatachalam TK; Mao C; Qazi S; Uckun FM
    Biol Reprod; 2002 Dec; 67(6):1959-74. PubMed ID: 12444075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lead optimization at C-2 and N-3 positions of thiazolidin-4-ones as HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Murugesan V; Tiwari VS; Saxena R; Tripathi R; Paranjape R; Kulkarni S; Makwana N; Suryawanshi R; Katti SB
    Bioorg Med Chem; 2011 Nov; 19(22):6919-26. PubMed ID: 21982685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial neural networks: non-linear QSAR studies of HEPT derivatives as HIV-1 reverse transcriptase inhibitors.
    Douali L; Villemin D; Zyad A; Cherqaoui D
    Mol Divers; 2004; 8(1):1-8. PubMed ID: 14964783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel simple QSAR model for the prediction of anti-HIV activity using multiple linear regression analysis.
    Afantitis A; Melagraki G; Sarimveis H; Koutentis PA; Markopoulos J; Igglessi-Markopoulou O
    Mol Divers; 2006 Aug; 10(3):405-14. PubMed ID: 16896545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-Benzyl and 4-benzoyl-3-dimethylaminopyridin-2(1H)-ones: in vitro evaluation of new C-3-amino-substituted and C-5,6-alkyl-substituted analogues against clinically important HIV mutant strains.
    Benjahad A; Croisy M; Monneret C; Bisagni E; Mabire D; Coupa S; Poncelet A; Csoka I; Guillemont J; Meyer C; Andries K; Pauwels R; de Béthune MP; Himmel DM; Das K; Arnold E; Nguyen CH; Grierson DS
    J Med Chem; 2005 Mar; 48(6):1948-64. PubMed ID: 15771439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triazole derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase--structure-activity relationships and crystallographic analysis.
    Kirschberg TA; Balakrishnan M; Huang W; Hluhanich R; Kutty N; Liclican AC; McColl DJ; Squires NH; Lansdon EB
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1131-4. PubMed ID: 18083512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.